BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 16866609)

  • 1. Zebrafish assays for drug toxicity screening.
    Rubinstein AL
    Expert Opin Drug Metab Toxicol; 2006 Apr; 2(2):231-40. PubMed ID: 16866609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zebrafish as a genetic model in pre-clinical drug testing and screening.
    Gibert Y; Trengove MC; Ward AC
    Curr Med Chem; 2013; 20(19):2458-66. PubMed ID: 23521675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small molecule screening in the zebrafish.
    Murphey RD; Zon LI
    Methods; 2006 Jul; 39(3):255-61. PubMed ID: 16877005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Zebrafish as a model organism for biomedical studies].
    Beliaeva NF; Kashirtseva VN; Medvedeva NV; Khudoklinova IuIu; Ipatova OM; Archakov AI
    Biomed Khim; 2010; 56(1):120-31. PubMed ID: 21328916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Editor's Highlight: Transgenic Zebrafish Reporter Lines as Alternative In Vivo Organ Toxicity Models.
    Poon KL; Wang X; Lee SG; Ng AS; Goh WH; Zhao Z; Al-Haddawi M; Wang H; Mathavan S; Ingham PW; McGinnis C; Carney TJ
    Toxicol Sci; 2017 Mar; 156(1):133-148. PubMed ID: 28069987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zebrafish model in drug safety assessment.
    Kanungo J; Cuevas E; Ali SF; Paule MG
    Curr Pharm Des; 2014; 20(34):5416-29. PubMed ID: 24502596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The zebrafish as a novel tool for cardiovascular drug discovery.
    Rocke J; Lees J; Packham I; Chico T
    Recent Pat Cardiovasc Drug Discov; 2009 Jan; 4(1):1-5. PubMed ID: 19149699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zebrafish: a complete animal model for in vivo drug discovery and development.
    Chakraborty C; Hsu CH; Wen ZH; Lin CS; Agoramoorthy G
    Curr Drug Metab; 2009 Feb; 10(2):116-24. PubMed ID: 19275547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo drug discovery in the zebrafish.
    Zon LI; Peterson RT
    Nat Rev Drug Discov; 2005 Jan; 4(1):35-44. PubMed ID: 15688071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zebrafish: an emerging model system for human disease and drug discovery.
    Kari G; Rodeck U; Dicker AP
    Clin Pharmacol Ther; 2007 Jul; 82(1):70-80. PubMed ID: 17495877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of the evaluation method for teratogenicity using zebrafish embryos.
    Yamashita A; Inada H; Chihara K; Yamada T; Deguchi J; Funabashi H
    J Toxicol Sci; 2014 Jun; 39(3):453-64. PubMed ID: 24849680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of zebrafish mutants to identify secondary target effects of acetylcholine esterase inhibitors.
    Behra M; Etard C; Cousin X; Strähle U
    Toxicol Sci; 2004 Feb; 77(2):325-33. PubMed ID: 14657522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zebrafish based assays for the assessment of cardiac, visual and gut function--potential safety screens for early drug discovery.
    Berghmans S; Butler P; Goldsmith P; Waldron G; Gardner I; Golder Z; Richards FM; Kimber G; Roach A; Alderton W; Fleming A
    J Pharmacol Toxicol Methods; 2008; 58(1):59-68. PubMed ID: 18585469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zebrafish (Danio rerio): A valuable tool for predicting the metabolism of xenobiotics in humans?
    de Souza Anselmo C; Sardela VF; de Sousa VP; Pereira HMG
    Comp Biochem Physiol C Toxicol Pharmacol; 2018 Oct; 212():34-46. PubMed ID: 29969680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioral profiling of zebrafish embryos exposed to a panel of 60 water-soluble compounds.
    Ali S; Champagne DL; Richardson MK
    Behav Brain Res; 2012 Mar; 228(2):272-83. PubMed ID: 22138507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zebrafish as a pharmacological tool: the how, why and when.
    Goldsmith P
    Curr Opin Pharmacol; 2004 Oct; 4(5):504-12. PubMed ID: 15351356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of the use of zebrafish larvae in visual safety assessment.
    Richards FM; Alderton WK; Kimber GM; Liu Z; Strang I; Redfern WS; Valentin JP; Winter MJ; Hutchinson TH
    J Pharmacol Toxicol Methods; 2008; 58(1):50-8. PubMed ID: 18541443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxicity assessments of nonsteroidal anti-inflammatory drugs in isolated mitochondria, rat hepatocytes, and zebrafish show good concordance across chemical classes.
    Nadanaciva S; Aleo MD; Strock CJ; Stedman DB; Wang H; Will Y
    Toxicol Appl Pharmacol; 2013 Oct; 272(2):272-80. PubMed ID: 23811329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zebrafish: a new model on the pharmaceutical catwalk.
    Langheinrich U
    Bioessays; 2003 Sep; 25(9):904-12. PubMed ID: 12938180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inter-laboratory assessment of a harmonized zebrafish developmental toxicology assay - progress report on phase I.
    Gustafson AL; Stedman DB; Ball J; Hillegass JM; Flood A; Zhang CX; Panzica-Kelly J; Cao J; Coburn A; Enright BP; Tornesi MB; Hetheridge M; Augustine-Rauch KA
    Reprod Toxicol; 2012 Apr; 33(2):155-64. PubMed ID: 22210281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.